Clinical Trial Update: Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

An early-phase trial evaluating orally administered AMG 900 in adults with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AMG 900

Snippet

Sponsor: Amgen | Conditions: Cancer, Hematologic Malignancies | Phase 1 | Status: COMPLETED